🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2001-12
Trial ID
NCT02046304
Treatments Being Tested
This is a multi-center clinical study enrolling up to 50 participants. The ...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2025-06-17
Trial ID
NCT06698458
Treatments Being Tested
Primary Objective: 1\. To assess resectability rate in patients undergoing...
Status
Completed
Location
U.T. M.D. Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00336648
Treatments Being Tested
This study is evaluating stereotactic radiosurgery (CyberKnife) plus chemot...
Status
Unknown
Location
MD Anderson Cancer Center at Cooper
Start Date
2013-01
Trial ID
NCT02707315
Treatments Being Tested
Purpose :To compare the efficacy and and safety of the P-Gemox chemotherapy...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2015-05
Trial ID
NCT02359162
The purpose of this study is to assess overall survival after treatment wit...
Status
Completed
Location
University of Alabama
Start Date
2010-04
Trial ID
NCT01072981
Treatments Being Tested
There is no a clear consensus regarding the optimal treatment of locally ad...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02984501
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
2009-06
Trial ID
NCT00601627
Treatments Being Tested
This phase Ib trial tests the safety, side effects, and best dose of leflun...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2024-05-13
Trial ID
NCT06454383
This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-21
Trial ID
NCT02427841